Suchergebnisse - "Kakuda, Thomas N"

PubPharm (114)

1

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analog suppressed patients with chronic hepatitis B : REEF-2

enthalten in: Journal of hepatology | 2024

von Agarwal, K. | Buti, M. | van Bömmel, F. | +14

2

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1) : a multicentre, double-blind, active-controlled, randomised, phase 2b trial

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Yuen, M. | Asselah, T. | Jacobson, I. | +116

CommentIn: Lancet Gastroenterol Hepatol. 2023 Sep;8(9):772-773. - PMID 37442151

3

Pharmacokinetics of JNJ-73763989 and JNJ-56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment

enthalten in: Journal of clinical pharmacology | 2023

von Kakuda, T. | Halabi, A. | Klein, G. | +12

4

Pharmacokinetics, Safety, and Tolerability of the siRNA JNJ-73763989 in Healthy Chinese Adult Participants

enthalten in: Clinical pharmacology in drug development | 2023

von Li, H. | Niu, X. | Zhang, Y. | +11

5

Pharmacokinetics, Safety, and Tolerability of the siRNA JNJ‐73763989 in Healthy Chinese Adult Participants

enthalten in: Clinical Pharmacology in Drug Development | 2023

von Li, H. | Niu, X. | Zhang, Y. | +11

6

Pharmacokinetics of JNJ‐73763989 and JNJ‐56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment

enthalten in: The Journal of Clinical Pharmacology | 2023

von Kakuda, T. | Halabi, A. | Klein, G. | +12

7

Drug-Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379 (Bersacapavir)

enthalten in: Clinical pharmacology in drug development | 2022

von Vandenbossche, J. | Yogaratnam, J. | Hillewaert, V. | +8

8

JNJ-73763989 pharmacokinetics and safety : Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B

enthalten in: Antiviral therapy | 2022

von Gane, E. | Yuen, M. | Kakuda, T. | +13

9

Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Gane, E. | Schwabe, C. | Berliba, E. | +12

10

Drug‐Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ‐56136379 (Bersacapavir)

enthalten in: Clinical Pharmacology in Drug Development | 2022

von Vandenbossche, J. | Yogaratnam, J. | Hillewaert, V. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]